May 29, 2026 FDA Expands Afrezza to Pediatric Diabetes The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data. Conexiant
May 27, 2026 FDA OKs Linaclotide in Young Children Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation. Conexiant
May 27, 2026 Ensitrelvir Reduced COVID After Household Exposure In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10. Conexiant
May 20, 2026 Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination. Conexiant
May 12, 2026 Makary Resigns as FDA Commissioner Following Policy Disputes Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization Conexiant
May 12, 2026 FDA Clears AI Sepsis Warning System An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%. Conexiant
May 04, 2026 FDA Expands ASCENIV Pediatric Use Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility. Conexiant
May 04, 2026 Food Fight Brewing in Hospitals New federal diet push collides with clinical realities, as doctors weigh patient needs against policy signals. Kff Health News
April 30, 2026 Urgent Care, Unchecked Power An unsupervised clinic model and blurred boundaries expose how oversight can fail in outpatient care. Conexiant
April 29, 2026 FDA Reports Results of Nationwide Infant Formula Testing Federal testing survey examines chemical contaminant profiles across widely used products Conexiant